Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- ‘No public health outbreak’: Colbert Co. school officials address student seizures
- Deprescribing: The long road off antidepressants
- Tennessee health firm settles false claims case for $2.4 million
- Pearl River County School District opens fitness trail
- XXL Nutrition’s innovative Protein Soup in collaboration with HAK
- Ask Dr. Nandi: Back-to-school common illnesses, when to keep kids home sick
- D&D Pharmatech to Unveil Muscle-Sparing Obesity Drug Data at U.S. Meeting
- I’m A Lifestyle Writer – 5 Health Habits Research Actually Made Me Change
Browsing: Wellness Tips
The telehealth firm widened its Q2 loss as branded GLP-1 drugs and international expansion pressured margins, even as it raised its full-year revenue outlook
Rapid weight loss is now a reality for millions of Americans, and the question of what happens to skin afterward has moved from cosmetic afterthought to front-of-mind concern. Whether pounds come off through medication, surgery, pregnancy recovery or diet and exercise, the skin that stretched to accommodate extra weight does not always snap back
Wontek (336570.KQ) is looking to extend the success of Olleodio, its radio-frequency aesthetic medical device, into devices for treating hair loss and obesity. As the markets for hair-loss and obesity treatment grow rapidly, the company is re-releasing upgraded versions of its existing approved devices while seeking hair-loss treatment approval for its aesthetic device Lavieien. It…
Cardiovascular-kidney-metabolic syndrome, or CKM syndrome, affects millions of Americans – but many may not know what signs to watch out for
The promise sounds tempting: reshape stubborn areas, tighten skin, and improve your silhouette without surgery or a lengthy recovery. Non-invasive body contouring treatments have become increasingly sophisticated, giving patients more options for addressing localized fat, skin laxity, and other aesthetic concerns
Chrissy Metz has opened up about using drugs on her weight-loss journey.The actor and singer, who is best known for playing Kate Pearson in the TV drama This Is Us from 2016 to 2022, has signed up as a celebrity brand ambassador for telehealth GLP-1 weight loss programme Ro
The This Is Us star, 45, has long been candid about her weight journey, which was even used as a plot line in the ABC drama, though she has also long been skeptical about GLP-1s, which approximately 10 million people (about 15%of American adults) have now tried
Chrissy Metz is opening up about her decision to use aGLP-1 medication after years of skepticism about the popular weight loss drugs. Here is what New Jersey residents need to know
Eli Lilly’s daily weight-loss pill orforglipron (Foundayo) has been authorised for use in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced
Chrissy Metz spoke publicly for the first time about her decision to use GLP-1 medication during an appearance on TODAY, where she also announced a new partnership with health care company Ro. Metz explained that she was originally skeptical of weight loss drugs before detailing how the medication has changed her life. In the same…

